Similarly, it has been found that CXC receptor activates ERK1/2 and stimulates meningioma cell proliferation [41], and in systematic investigation of quercetin for cardiovascular disease treatment, CXCL8 is enriched in the TNF signaling and IL-17 signaling pathways [42]. Here, IL17A is linked to meningioma.